Publicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (22)

2024

  1. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2023

  1. Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells

    Frontiers in Cell and Developmental Biology, Vol. 11

  2. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome

    Journal of Molecular Medicine, Vol. 101, Núm. 12, pp. 1587-1601

2022

  1. Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria

    Science Translational Medicine, Vol. 14, Núm. 627

2020

  1. Brain ventricular enlargement in human and murine acute intermittent porphyria

    Human molecular genetics, Vol. 29, Núm. 19, pp. 3211-3223

  2. Click Synthesis of Size-and Shape-Tunable Star Polymers with Functional Macrocyclic Cores for Synergistic DNA Complexation and Delivery

    Biomacromolecules, Vol. 21, Núm. 12, pp. 5173-5188

2018

  1. Adrenomedullin, a Novel Target for Neurodegenerative Diseases

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 8799-8814

  2. Advances in parkinson’s disease: 200 years later

    Frontiers in Neuroanatomy, Vol. 12

  3. Association of lifestyle, inflammatory factors, and dietary patterns with the risk of suffering a stroke: A case–control study

    Nutritional Neuroscience, Vol. 21, Núm. 1, pp. 70-78

  4. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

  5. Reduced Adrenomedullin Parallels Microtubule Dismantlement in Frontotemporal Lobar Degeneration

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 9328-9333

2017

  1. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001

2016

  1. Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys

    Biomaterials, Vol. 110, pp. 11-23

  2. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease

    Brain, Behavior, and Immunity, Vol. 57, pp. 94-105

2015

  1. Epigenetic changes in the methylation patterns of KCNQ1 and WT1 after a weight loss intervention program in obese stroke patients

    Current Neurovascular Research, Vol. 12, Núm. 4, pp. 321-333

  2. Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells

    Human Molecular Genetics, Vol. 24, Núm. 5, pp. 1432-1440

2011

  1. Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex

    European Neuropsychopharmacology, Vol. 21, Núm. 1, pp. 23-32

  2. Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease

    Movement Disorders, Vol. 26, Núm. 10, pp. 1943-1947

2010

  1. Regulation of markers of synaptic function in mouse models of depression: Chronic mild stress and decreased expression of VGLUT1

    Journal of Neurochemistry, Vol. 114, Núm. 5, pp. 1302-1314

  2. Sustained stress-induced changes in mice as a model for chronic depression

    Psychopharmacology, Vol. 210, Núm. 3, pp. 393-406